For patients with IIH, sustainable weight loss offers the most effective and lasting relief from symptoms—and can help ...

Brain swelling, or cerebral edema, is a medical emergency. Learn about the evidence-based treatments doctors use to reduce ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

Liraglutide, a medication commonly used to treat diabetes, has shown promising results in reducing chronic migraine in ...

Medications sold under brand names like Ozempic, Wegovy, and Saxenda have become famous for their weight-loss benefits, but ...

A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity and ...

A GLP-1 medication used to treat type 2 diabetes and obesity may help cut a person's monthly migraine days by about half, a ...

People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, researchers in Italy have found.

“That would pose intracranial pressure control as a brand-new, pharmacologically targetable pathway.” Mild gastrointestinal ...

Brain tumours may lead to headaches by raising pressure inside the skull compressing sensitive structures or disrupting the ...

Researchers at the Headache Centre of the University of Naples “Federico II” gave the glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide to 26 adults with obesity and chronic migraine.